Evidence map›Paper›PMID 33758844›Full record

ArticlebioRxiv : the preprint server for biology2021

SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection.

Laura Bashor, Roderick B Gagne, Angela Bosco-Lauth, Richard Bowen, Mark Stenglein, Sue VandeWoude

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 20 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Laura BashorDepartment of Microbiology, Immunology, and Pathology, Colorado State University; Fort Collins, CO, 80523, USA.
Roderick B GagneDepartment of Pathobiology, Wildlife Futures Program, University of Pennsylvania School of Veterinary Medicine; Kennett Square, PA, 19348, USA.
Angela Bosco-LauthDepartment of Biomedical Sciences, Colorado State University; Fort Collins, CO, 80523, USA.
Richard BowenDepartment of Biomedical Sciences, Colorado State University; Fort Collins, CO, 80523, USA.
Mark StengleinDepartment of Microbiology, Immunology, and Pathology, Colorado State University; Fort Collins, CO, 80523, USA.
Sue VandeWoudeDepartment of Microbiology, Immunology, and Pathology, Colorado State University; Fort Collins, CO, 80523, USA.
Collins College · USThe Wildlife Society · US

Funding

NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
NCATS NIH HHS UL1 TR002535
6 · The paper itself

Abstract

SARS-CoV-2 spillback from humans into domestic and wild animals has been well-documented. We compared variants of cell culture-expanded SARS-CoV-2 inoculum and virus recovered from four species following experimental exposure. Five nonsynonymous changes in nsp12, S, N and M genes were near fixation in the inoculum, but reverted to wild-type sequences in RNA recovered from dogs, cats and hamsters within 1-3 days post-exposure. Fourteen emergent variants were detected in viruses recovered from animals, including substitutions at spike positions H69, N501, and D614, which also vary in human lineages of concern. The rapidity of in vitro and in vivo SARS-CoV-2 selection reveals residues with functional significance during host-switching, illustrating the potential for spillback reservoir hosts to accelerate evolution, and demonstrating plasticity of viral adaptation in animal models. ONE-SENTENCE SUMMARY: SARS-CoV-2 variants rapidly arise in non-human hosts, revealing viral evolution and potential risk for human reinfection.

Identifiers

PMID33758844
PMCPMC7987003
OpenAlexW3135650141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.